Gene set enrichment analysis (GSEA) was performed to identify the signaling pathways related to the regulatory mechanism of FAM64A. Our results indicate that FAM64A may be a useful biomarker for the diagnosis and prognosis of pancreatic cancer. Here, PIMREG is linked to familial pancreatic carcinoma.